News & Events

First Half of 2022 publications highlight

Our off-the-shelf and custom animal and cell models are advancing cutting-edge biomedical research every day. One measure of this impact is how often they appear…

Read more
Webinar: Preclinical Models to Investigate NK Cell-Targeted Immunotherapies

Our webinar “Preclinical Models to Investigate NK Cell-Targeted Immunotherapies" will be live on Aug 31, 2022 at 1PM EDT. In this webinar, we will: Review…

Read more
10th annual Immuno-Oncology Summit

Attend the meeting Talk to us Over the past 10 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied…

Read more
18th International SCBA Symposium

Attend the meeting Talk to us The Society of Chinese Bioscientists in America (SCBA) is a non-profit organization founded by a few prominent and enthusiastic bioscientists…

Read more
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs

Beijing, China and Tokyo, Japan, July 21, 2022 – February 1st 2021,  Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered a strategic collaboration with LiberoThera Co.,…

Read more
Basic Cardiovascular Sciences Scientific Sessions 2022

Attend the meeting Talk to us at booth 9 The annual BCVS Scientific Sessions is one of largest meetings in the world dedicated to fundamental…

Read more
Biocytogen/Eucure Biopharma Announce First Patient Dosed in Phase II Clinical Trial of YH003 Combination Therapy as a First-Line Treatment for Mucosal Melanoma

Beijing, China, July 12, 2022 -- Biocytogen subsidiary Eucure Biopharma announced that the first patient has been dosed in a phase II clinical trial (No.…

Read more
Tumor Models Boston 2022

Attend the meeting Talk to us Meet our expert scientists to learn about our recent advances in preclinical drug evaluation, which includes new humanized animal…

Read more
EACR 2022 Congress

EACR 2022 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest…

Read more
Biocytogen Europe Innovation Center Team to Present at AET-EU 2022, Introducing Project Integrum, TCR-mimic Platform and YH012

Beijing and Heidelberg, June 3, 2022 -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") today announced 3 poster presentations for two novel fully human antibody platforms…

Read more
Back to top